Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients ...

The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...

“Mounjaro’s changed my life and it might have even saved my life,” Mark said. “I couldn’t walk across the car park in June ...

THE family of a man who died after taking Mounjaro want a probe into the weight-loss drug’s “potential to kill”. It comes after The Sun revealed 82 deaths have been linked to anti-fat and diabetes ...

It comes as companies work to build goodwill with Trump, who has emphasized reshoring manufacturing to the U.S. and reducing ...

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...

US pharmaceutical giant Eli Lilly announced Wednesday that it will build four additional new manufacturing sites in the ...

People with a high body weight living in England can now access subsidized weight-loss drugs to treat their obesity. This ...

Ozempic, Mounjaro and Wegovy may not be the lightbulb, jet airplane or internet, but their impact is expected to be so ...

Viking Therapeutics (NASDAQ: VKTX) soared into the spotlight about a year ago when it delivered promising data on a drug ...

New research finds older women achieve the best results with weight loss injections – thanks to consistent tracking and ...